コンテンツへスキップ
Merck
  • Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2.

Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2.

International journal of pharmaceutics (2015-03-01)
Ankita Shah, Abu T M Serajuddin
要旨

A novel method of greatly increasing solubility and dissolution rate of a model basic drug, haloperidol, by interacting it with water-soluble weak organic acids in aqueous media was previously reported in the literature. Amorphous solid dispersion (SD) was formed when solutions containing haloperidol and various acids were dried. However, the SDs were semisolid, viscous and sticky, especially when the drug load was high, and could not be processed into tablets. The drug release from SD was also incomplete since the viscous material did not readily mix with aqueous media. In the present study, a mesoporous metalosilicate, Neusilin(®) US2, was incorporated in SDs prepared by using malic, tartaric and citric acids. The silicate constituted 40% w/w of the total solid mass. The addition of silicate converted SDs into powders, which were then characterized for flow properties, bulk and tap density, and tabletability. Their physical properties were found to be acceptable for the development of tablets. DSC and powder XRD showed that haloperidol and acids converted completely to amorphous forms, and they did not show any sign of crystallization during accelerated stability study at 40°C/75% RH and 25°C/60% RH for 9 months. Complete drug release under gastrointestinal pH conditions could be obtained from tablets prepared.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
クエン酸, meets analytical specification of Ph. Eur., BP, USP, E330, anhydrous, 99.5-100.5% (based on anhydrous substance)
Sigma-Aldrich
DL-リンゴ酸, ReagentPlus®, ≥99%
Sigma-Aldrich
クエン酸, ≥99.5%, FCC, FG
Sigma-Aldrich
クエン酸, anhydrous, suitable for cell culture, suitable for plant cell culture
USP
クエン酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
クエン酸, BioUltra, anhydrous, ≥99.5% (T)
Sigma-Aldrich
クエン酸, ACS reagent, ≥99.5%
Sigma-Aldrich
ステアリン酸マグネシウム, technical grade
Sigma-Aldrich
DL-リンゴ酸, 99%
Sigma-Aldrich
ハロペリドール, powder
Sigma-Aldrich
クエン酸, 99%
USP
リンゴ酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
DL-リンゴ酸, ≥98% (capillary GC)
Sigma-Aldrich
2-Hydroxybutyric acid sodium salt, 97%
Supelco
クエン酸、無水, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L(+)-酒石酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
クエン酸, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.5%
Supelco
DL-リンゴ酸, Pharmaceutical Secondary Standard; Certified Reference Material
USP
ハロペリドール, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
ステアリン酸マグネシウム, puriss., meets analytical specification of Ph. Eur., BP, ≥90% stearic and palmitic acid basis, ≥40% stearic acid basis (GC), 4.0-5.0% Mg basis (calc on dry sub.)
Sigma-Aldrich
DL-リンゴ酸, SAJ first grade, ≥99.0%
Sigma-Aldrich
ステアリン酸マグネシウム, SAJ first grade
Sigma-Aldrich
クエン酸, SAJ first grade, ≥99.5%
Supelco
クエン酸, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Malic acid, meets USP/NF testing specifications
クエン酸, anhydrous, European Pharmacopoeia (EP) Reference Standard
Supelco
DL-リンゴ酸, analytical standard
ハロペリドール, European Pharmacopoeia (EP) Reference Standard
システム適合性用ハロペリドール, European Pharmacopoeia (EP) Reference Standard
ハロペリドール, European Pharmacopoeia (EP) Reference Standard